Clinical and economic evaluation of risk factor guided respiratory syncytial virus prophylaxis in Colombian preterm infants

Key Points

• Prophylaxis reduces the incidence of respiratory syncytial virus in preterm infants, enhancing clinical outcomes.
• The economic evaluation shows cost savings associated with risk factor guided prophylaxis across preterm infants.
• Assessment of clinical data from multiple healthcare facilities supports the intervention's effectiveness.
• Highlights the need for tailored approaches in RSV prevention strategies for vulnerable populations.